rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1994-10-13
|
pubmed:abstractText |
Uterine papillary serous adenocarcinoma (UPSA) is a highly aggressive neoplasm with a great tendency for dissemination. p53 and c-erbB-2 immunoreactivity and DNA ploidy are considered to be indicators of prognosis for endometrial carcinomas.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1778-83
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7915964-Adult,
pubmed-meshheading:7915964-Aged,
pubmed-meshheading:7915964-Aged, 80 and over,
pubmed-meshheading:7915964-Cystadenocarcinoma, Papillary,
pubmed-meshheading:7915964-DNA, Neoplasm,
pubmed-meshheading:7915964-Female,
pubmed-meshheading:7915964-Humans,
pubmed-meshheading:7915964-Middle Aged,
pubmed-meshheading:7915964-Neoplasm Staging,
pubmed-meshheading:7915964-Ploidies,
pubmed-meshheading:7915964-Proto-Oncogene Proteins,
pubmed-meshheading:7915964-Receptor, Epidermal Growth Factor,
pubmed-meshheading:7915964-Receptor, erbB-2,
pubmed-meshheading:7915964-Tumor Markers, Biological,
pubmed-meshheading:7915964-Tumor Suppressor Protein p53,
pubmed-meshheading:7915964-Uterine Neoplasms
|
pubmed:year |
1994
|
pubmed:articleTitle |
Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content.
|
pubmed:affiliation |
Department of Pathology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|